SHC

Petras Michael B. Jr.

Known title: Chairman & CEOCIK: 0001832387

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 16, 2026

SHC Downgraded to Underweight by JP Morgan, Price Target Set at $17. JP Morgan lowered its rating on Sotera Health to Underweight and issued a new price target of $17. The downgrade came after the company's recent earnings discussion, which highlighted its current operational performance. Observers also note that the stock has risen about 35% recently, raising questions about its valuation relative to the new target.

this person other insiders at SHC

Transaction History

SHC▼ Sell$5.4M
SHC▼ Sell$15.7M
SHC▼ Sell$499K
SHC▼ Sell$641K
SHC▲ Buy—
SHC▼ Sell$629K
SHC▼ Sell$1.3M
SHC▲ Buy$0
SHC▼ Sell$5.2M
SHC▼ Sell$6.5M
SHC▼ Sell$646K
SHC▲ Buy$0
SHC▼ Sell$349K
SHC▼ Sell$397K
SHC▼ Sell$511K
SHC▼ Sell$0
SHC▼ Sell$0
SHC▼ Sell$386K
SHC▼ Sell$0
SHC▲ Buy$0
SHC▼ Sell$14.4M
SHC▼ Sell$408K
SHC▼ Sell$314K
SHC▼ Sell$407K
SHC▲ Buy$0
SHC▼ Sell$345K
SHC▼ Sell$176K
SHC▲ Buy$0
SHC▼ Sell$620K

We use analytics to understand how market-wall is used. No personal data is sold.